We report a chemical route to colloidal silicon (Si) nanocrystals, or quantum dots, with widely tunable average diameter, from less than 3 nm up to 90 nm and peak photoluminescence (PL) from visible wavelengths to the bulk band gap of Si at 1100 nm. The synthesis relies on the high temperature (>1100 °C) decomposition of hydrogen silsesquioxane (HSQ) to obtain Si quantum dots with good crystallinity and a narrow size distribution with tunable size embedded in SiO 2 . The oxide matrix is removed by hydrofluoric acid etching in the dark. Subsequent thermal hydrosilylation with alkenes yields free, solvent-dispersible Si nanocrystals with bright PL. The relationship between PL energy and size, exhaustively characterized by transmission electron microscopy (TEM), small-angle X-ray scattering (SAXS), and X-ray diffraction (XRD), is reported.

Oxide-embedded and oxide-free alkyl-terminated silicon (Si) nanocrystals with diameters ranging from 3 nm to greater than 10 nm were studied by Raman spectroscopy. For ligand-passivated nanocrystals, the zone center Raman-active mode of diamond cubic Si shifted to lower frequency with decreasing size, accompanied by asymmetric peak broadening, as extensively reported in the literature. The size dependence of the Raman peak shifts, however, was significantly more pronounced than previously reported or predicted by the RWL (Richter, Wang, and Ley) and bond polarizability models. In contrast, Raman peak shifts for oxide-embedded nanocrystals were significantly less pronounced as a result of the stress induced by the matrix.

No abstract

The imaginary part of the dielectric constant (ε2) and the band gap energy (Eg) of as-deposited and crystallized HfO2 and La-incorporated HfO2 (La–HfO2) are extracted from spectroscopic ellipsometry. As-deposited amorphous HfO2 and La–HfO2 have similar absorption tails, which implies the existence of disorder in the amorphous film structure. Upon crystallization, the absorption tails are reduced and Eg increases for both HfO2 and La–HfO2. But disorder still exists and interband states form in pure HfO2, whereas disorder in crystalline La–HfO2 is largely reduced, which might be the result of La atoms incorporating into the HfO2 host, forming a new HfLaxOy network after crystallization.

BackgroundFamily with sequence similarity 57 member A (FAM57A) is a membrane associated gene contributing to lung carcinogenesis. In hepatocellular carcinoma (HCC) and other cancers, whether FAM57A exerts similar roles has been rarely reported. Herein, the biological functions and clinical significance of FAM57A in HCC were explored.MethodsInitially the differential expression of FAM57A between nontumor and HCC tissues was validated using a number of publicly accessible databases and immunohistochemistry (IHC). Then, the Kruskal–Wallis rank sum test or the Wilcoxon rank sum test as well as logistic regression were employed to analyze the association of FAM57A expression with clinical characteristics of HCC. The Cox regression and Kaplan–Meier analyses were conducted to assess the prognostic significance. Besides, with the coexpression analysis, Gene Ontology (GO), Gene Set Enrichment Analysis (GSEA), and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis, the molecular pathomechanisms that were mediated by FAM57A in HCC were elucidated. Furthermore, the correlations between FAM57A expression and tumor-infiltrating immune cells (TIICs) or immune checkpoint genes were analyzed. Finally, in vitro cell functional assay was carried out to preliminarily verify the role of FAM57A in HCC.ResultsFAM57A expression was demonstrated to be higher in HCC samples than in nontumor samples (all p-values <0.05), statistically correlated with clinicopathological characteristics (clinical stage, T stage, pathological grade), and inversely correlated to HCC patient survival. Univariate and multivariate Cox regression analyses showed that FAM57A expression could independently predict prognosis in HCC patients. Functional enrichment analyses further indicated that FAM57A was involved in multiple tumor-related pathways. FAM57A expression was positively correlated with TIICs, gene markers of TIICs, as well as immune checkpoint genes. Also, high expression of FAM57A predicted a poor prognosis for HCC based on immune cell subgroups. Functional assay of FAM57A knockdown significantly inhibited cell proliferation and induced cell apoptosis in HCC cells.ConclusionsOur results indicated that FAM57A could be used as a biomarker to predict the prognosis and immunotherapy response for HCC patients and might function as an oncogene to promote HCC progression.